| |
Data available from N |
Confirmed |
| Positive finding N |
(%) |
| no comorbidity |
- |
47 |
(39.7%) |
| 1 underlying condition |
- |
27 |
(22.5%) |
| 2 underlying conditions |
- |
22 |
(18.3%) |
| >2 underlying conditions |
- |
24 |
(20.0%) |
| Risk factors |
- |
- |
- |
| Chronic cardiovascular disease |
129 |
37 |
(28.7%) |
| Chronic pulmonary disease |
129 |
35 |
(27.1%) |
| Asthma |
129 |
15 |
(11.6%) |
| COPD |
129 |
12 |
(9.3%) |
| Immunosuppression |
129 |
22 |
(17.1%) |
| BMI>25 |
120 |
50 |
(41.4%) |
| BMI>30 |
120 |
16 |
(13.3%) |
| BMI>40 |
120 |
3 |
(2.5%) |
| IV drug abuse |
129 |
12 |
(9.3%) |
| Malignancy |
129 |
9 |
(7.0%) |
| Chronic liver disease |
129 |
9 |
(7.0%) |
| Chronic neurological disease |
129 |
9 |
(7.0%) |
| Diabetes |
129 |
7 |
(5.4%) |
| Chronic renal disease |
129 |
3 |
(2.3%) |
| Pregnancy (1) |
70 |
5 |
(7.1%) |
(1) Total number of womens was 70 |
